Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABS) Change in Interest Receivables: 2024

Historic Change in Interest Receivables for SAB Biotherapeutics (SABS) over the last 1 years, with Dec 2024 value amounting to $54,955.

  • SAB Biotherapeutics' Change in Interest Receivables rose 537.88% to $559,954 in Q3 2025 from the same period last year, while for Sep 2025 it was $462,907, marking a year-over-year change of. This contributed to the annual value of $54,955 for FY2024, which is N/A change from last year.
  • SAB Biotherapeutics' Change in Interest Receivables amounted to $54,955 in FY2024.
  • SAB Biotherapeutics' Change in Interest Receivables' 5-year high stood at $54,955 during FY2024, with a 5-year trough of $54,955 in FY2024.
  • In the last 1 years, SAB Biotherapeutics' Change in Interest Receivables had a median value of $54,955 in 2024 and averaged $54,955.